446
Participants
Start Date
March 16, 2018
Primary Completion Date
November 14, 2018
Study Completion Date
November 14, 2018
GSP 301 NS
1 spray in each nostril twice daily for 14 days
GSP 301 Placebo NS
1 spray in each nostril twice daily for 14 days
Glenmark Investigational Site 18, Mission Viejo
Glenmark Investigational Site 8, Raleigh
Glenmark Investigational Site 6, Spartanburg
Glenmark Investigational Site 13, Marietta
Glenmark Investigational Site 26, Savannah
Glenmark Investigational Site 28, Louisville
Glenmark Investigational Site 11, Cincinnati
Glenmark Investigational Site 29, Cincinnati
Glenmark Investigational Site 25, Ypsilanti
Glenmark Investigational Site 23, Greenfield
Glenmark Investigational Site 27, Warrensburg
Glenmark Investigational Site 12, Columbia
Glenmark Investigational Site 10, Rolla
Glenmark Investigational Site 15, Omaha
Glenmark Investigational Site 2, Edmond
Glenmark Investigational Site 33, Tulsa
Glenmark Investigational Site 20, Waco
Glenmark Investigational Site 31, Waco
Glenmark Investigational Site 1, New Braunfels
Glenmark Investigational Site 9, San Antonio
Glenmark Investigational Site 5, Austin
Glenmark Investigational Site 21, Colorado Springs
Glenmark Investigational Site 22, Draper
Glenmark Investigational Site 30, Paramount
Glenmark Investigational Site 17, San Diego
Glenmark Investigational Site 32, Ontario
Glenmark Investigational Site 14, Baltimore
Glenmark Investigational Site 19, Bethesda
Glenmark Investigational Site 3, High Point
Glenmark Investigational Site 4, Medford
Glenmark Investigational Site 24, Kerrville
Glenmark Investigational Site 7, San Antonio
Glenmark Specialty S.A.
INDUSTRY